US Orthopedic Biomaterial Industry Set to Reach USD 18.6 Billion by 2035
The US Orthopedic Biomaterial Industry is entering a strong growth phase as aging populations, increasing orthopedic procedures, advanced biomaterial technologies, and expanding healthcare infrastructure reshape the regional industry. The market is projected to reach USD 9.8 billion in 2026 and is expected to climb to USD 18.6 billion by 2035, representing a 7.4% CAGR from 2026 to 2035.
The outlook reflects sustained demand for biomaterials used in joint reconstruction, spinal fusion, trauma fixation, bone grafting, and other orthopedic procedures. Growing rates of osteoarthritis, osteoporosis-related fractures, and degenerative spinal conditions are creating a durable clinical need for orthopedic implants and bone-healing solutions across North America and Latin America.
US Orthopedic Biomaterial Industry: Key Highlights
- Market size reaches USD 9.8 billion in 2026.
- Market projected to hit USD 18.6 billion by 2035.
- Market expected to expand at a 7.4% CAGR.
- Metallic biomaterials lead with 44.6% share in 2026.
- Joint reconstruction leads applications at 41.8%.
- Hospitals account for 64.2% of end-user demand.
- North America represents 79.3% of the 2026 market.
- Latin America records the fastest regional CAGR at 10.1%.
- Ceramic biomaterials grow at a projected 9.6% CAGR.
- Bone graft substitutes advance at a 9.9% CAGR.
- Ambulatory Surgical Centers post a 10.8% CAGR.
- 3D printing is enabling patient-specific implant designs.
Get free sample of the report - https://dimensionmarketresearch.com/request-sample/americas-orthopedic-biomaterial-market/
Aging Population Supports Long-Term Market Expansion
Demographic change remains one of the most important growth factors for the US Orthopedic Biomaterial Industry. The aging population in the United States and Canada, combined with increasing healthcare access in Latin America, is contributing to a greater incidence of osteoarthritis, osteoporosis-related fractures, and degenerative spinal disorders.
These conditions frequently require joint replacement, spinal fusion, fracture fixation, or bone-healing procedures. As procedure volumes increase, demand is also rising for metallic, polymeric, ceramic, and biological biomaterials.
Technology innovation is adding another layer of growth. Advanced PEEK, highly cross-linked polyethylene, calcium phosphate, hydroxyapatite, collagen, and demineralized bone matrix products are expanding material choices for surgeons seeking improved implant longevity, biocompatibility, bone integration, and healing performance.
Metallic Biomaterials Maintain Market Leadership
Metallic biomaterials are projected to remain the largest material category, holding a 44.6% share in 2026. Titanium, cobalt-chromium alloys, and stainless steel continue to play an important role in joint reconstruction and trauma fixation because of their established clinical applications and mechanical performance.
However, ceramics represent an increasingly attractive growth area. The ceramic biomaterials segment is projected to expand at 9.6% CAGR through 2035, supported by broader use of calcium phosphate and hydroxyapatite in bone graft substitute and reconstructive applications.
Polymeric and biological materials are also gaining importance as manufacturers develop solutions designed to improve imaging, wear resistance, bone regeneration, and implant longevity.
Joint Reconstruction Remains the Leading Application
Joint reconstruction is anticipated to account for 41.8% of the US Orthopedic Biomaterial Industry in 2026. High procedure volumes for hip and knee replacement, particularly among older populations, continue to support demand for advanced orthopedic biomaterials.
Bone graft substitutes, meanwhile, are expected to be the fastest-growing application, with a projected 9.9% CAGR. Synthetic and biological alternatives can help surgeons reduce dependence on autologous bone harvesting while supporting bone regeneration in spinal, trauma, and reconstructive procedures.
Hospitals Dominate While Outpatient Care Gains Momentum
Hospitals are expected to represent 64.2% of the market in 2026, reflecting the complexity of orthopedic procedures and the need for comprehensive surgical infrastructure.
At the same time, Ambulatory Surgical Centers are becoming an important growth channel. The segment is projected to record a 10.8% CAGR, reflecting the broader shift toward efficient outpatient orthopedic procedures where clinically appropriate.
This transition is encouraging manufacturers to develop biomaterials, instruments, and procedural solutions that can support streamlined ambulatory workflows.
North America Leads, Latin America Offers New Opportunities
North America is projected to dominate the regional market with a 79.3% share in 2026, supported by healthcare expenditure, established hospital infrastructure, orthopedic expertise, and strong adoption of advanced medical technologies.
Latin America offers a significant longer-term growth opportunity. Brazil, Mexico, Colombia, and Argentina are expanding healthcare infrastructure and orthopedic surgical capabilities. The Latin American market is expected to grow at a 10.1% CAGR through 2035, creating opportunities for manufacturers, distributors, and healthcare providers.
3D Printing and Biological Biomaterials Reshape the Industry
3D printing is emerging as an important technology trend within the US Orthopedic Biomaterial Industry. Additive manufacturing can enable patient-specific implant geometries and porous structures designed to support bone ingrowth.
Advanced biological materials are another major opportunity. Demineralized bone matrix, collagen-based products, and other osteoinductive solutions are attracting interest because of their potential to actively support natural bone regeneration.
Robotic-assisted surgery and surgical navigation are also contributing to greater precision in implant placement, particularly in joint reconstruction and spinal procedures.
Competitive Landscape
The market features large global orthopedic companies, specialized biomaterial manufacturers, biological product developers, and regional distributors. Competition increasingly centers on clinical outcomes, material science innovation, surgeon education, hospital relationships, regulatory expertise, and distribution capabilities.
Prominent companies identified in the market include Stryker, Zimmer Biomet, DePuy Synthes, Medtronic, Smith+Nephew, Globus Medical, Arthrex, Enovis, Orthofix, Exactech, Bioventus, Cerapedics, BONESUPPORT, CeramTec, Evonik, Invibio Biomaterial Solutions, and other industry participants.
Recent developments also demonstrate continued innovation. In 2026, Isto Biologics acquired NovaBone Products, while the U.S. FDA expanded indications for Cerapedics' PearlMatrix P-15 Peptide Enhanced Bone Graft. Globus Medical also introduced the COHERE ALIF Spacer featuring porous PEEK technology in 2025.
Market Outlook
Overall, the US Orthopedic Biomaterial Industry presents a favorable long-term growth outlook. Aging demographics, rising orthopedic procedure volumes, materials innovation, biological biomaterial development, 3D printing, and Latin American infrastructure investment are expected to remain central to market expansion.
At the same time, reimbursement constraints and healthcare cost-containment policies could influence adoption of premium biomaterials. Manufacturers that combine strong clinical evidence with differentiated materials, efficient manufacturing, surgeon education, and regional market expertise are likely to be better positioned to capture emerging opportunities through 2035.
FAQ's
- What is the US Orthopedic Biomaterial Industry size in 2026?
The US Orthopedic Biomaterial Industry is projected to reach USD 9.8 billion in 2026.
- What will the US Orthopedic Biomaterial Industry be worth by 2035?
The market is forecast to reach approximately USD 18.6 billion by 2035.
- What is the CAGR of the US Orthopedic Biomaterial Industry?
The market is projected to expand at a 7.4% CAGR between 2026 and 2035.
- Which material type leads the US Orthopedic Biomaterial Industry?
Metallic biomaterials are expected to lead, accounting for 44.6% of the market in 2026.
- Which application dominates the market?
Joint reconstruction is projected to be the leading application, with a 41.8% share in 2026.
- Why is the US Orthopedic Biomaterial Industry growing?
Growth is driven by aging populations, rising orthopedic procedures, biomaterial innovation, and healthcare infrastructure investment.
- Which end user dominates the market?
Hospitals are projected to lead the end-user segment with a 64.2% share in 2026.
- Which region dominates the Americas market?
North America is expected to lead with a 79.3% share in 2026.
- Which regional market is growing fastest?
Latin America is projected to record the fastest growth, with a 10.1% CAGR through 2035.
- What are the key trends in orthopedic biomaterials?
Major trends include 3D-printed implants, advanced PEEK, ceramics, biological biomaterials, and outpatient orthopedic care.
Browse More Report:
About Us
Dimension Market Research (DMR) is a global market intelligence and consulting firm delivering data-driven insights that help organizations make informed strategic decisions. With expertise across 12+ industries and global markets, DMR provides syndicated reports, custom research, competitive analysis, white space analysis, and business strategy consulting.
Our research solutions combine analytical rigor, industry expertise, and forward-looking intelligence to identify opportunities, reduce risks, and support sustainable growth. Trusted by clients across diverse sectors, DMR is committed to delivering accurate, actionable insights that enable businesses to navigate evolving market landscapes with confidence.
Contact Us
Phone USA: +17323699777
Phone India: +919310023843
E-mail: enquiry@dimensionmarketresearch.com
Address USA: 957 Route 33, Suite 12 #308, Hamilton Square, NJ-08690
Address India: D44, Sector 6, Noida 201301, India
Comments (0)